drugset / Trial / NCT02057406

Omega 3 for Treatment of Depression in Patients With Heart Failure

NCT02057406 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Omega 3 supplements will improve depressive symptoms to a greater extent than placebo in heart failure patients with moderate to severe major depressive disorder.

Timeline

Start
2014-05
Primary completion
2016-05-19
Completion
2016-12-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator 2:1 EPA/DHA Other / unclassified 2 g —
Comparator High EPA Other / unclassified 2 g —